A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

Trump’s actions show all the signs of a vendetta against the scientists who embarrassed him during the COVID pandemic. When ...

A new study reveals that bacterial cells growing in a solution of polymers, like mucus, form long cables that act like a ...

Experts call the health implications “dire” with some fearing Kennedy could set off a fresh round in the school culture wars ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Vast Therapeutics, a clinical-stage life science company, today announced that it has been awarded a nearly two million dollar grant from the National Institutes of Health (NIH).1 The two-year project ...

The first of two season-defining games for both Pitt and UNC will boil down to, in my mind, what each of their letters mean.

Don't miss out on Boston-area life science news. Subscribe to the Morning ... the heels of an FDA approval for its new once-daily cystic fibrosis drug. And, it could receive approval by the ...

If Elliot Cadeau and Caleb Wilson end up playing together, they could become the combination UNC needs during this ...

Professor John Tregoning tells Nick Harding about the two years he spent testing longevity boosting theories to see if any work - his findings were surprising ...

EU-backed researchers and doctors are pioneering advanced pre-implantation and prenatal genetic testing to improve the chance ...